Any of these blue chip stocks would be solid long-term picks. One of them, however, is especially underestimated right now.

Working during retirement could be a great decision for both your finances and your general well-being. A part-time job can ...

Vertex Pharmaceuticals (VRTX 1.39%) is making its biggest bet in years. On Monday, the company agreed to acquire Crinetics ...

Raymond James analyst Brian Gesuale initiated coverage on the stock with a strong buy rating and a Street-high price target ...

Micron stock has soared about 242% in 2026 as of this writing, and it crossed $1 trillion in market value along the way. A run like that doesn't happen unless the market is already counting on blowout ...

Ives assigned SpaceX an outperform rating and a 12-month price target of $190. This implies roughly 18% upside from where it ...

Its acquisition of Cursor demonstrates that it recognizes the importance of creating a robust AI platform -- but it also ...

According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see from the chart below, ...

Shares of Meta Platforms (META +2.59%) were heading lower last month as a slew of concerns mounted for the social media giant ...

JPMorgan analyst Chris Schott reiterated his overweight (read: buy) rating on Eli Lilly's stock and boosted his share price ...

Currently, only a small percentage of SpaceX stock, less than 5% of shares outstanding, is publicly traded, which means that the space stock makes up less than 1% of the Nasdaq-100 index. However, ...

Based on Rivian’s closing price of $20.14 per share on July 6, the offering would raise slightly over $1.5 billion. Here’s ...